AI improved risk prediction before gastric cancer surgery and outperformed clinical scores. Find out how it may support ...

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study This is a single-institution ...

Gastric adenocarcinoma arises from the malignant transformation of gastric epithelium, driven by a confluence of environmental, microbial and molecular factors. Chronic infection with Helicobacter ...

Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) demonstrated a statistically significant and highly clinically meaningful ...

Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...

The U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with ...

They're cancers that form in the cells lining your stomach or your esophagus, the tube that carries food from your mouth to your stomach. They can behave differently depending on where they start. But ...

Tislelizumab-jsgr approved with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma, showing significant survival benefits. RATIONALE-305 study demonstrated a 20% ...

Changing Landscape of Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma Treatment and Survival Trends in Thailand: A 13-Year Multicenter Retrospective Study of Patients The majority ...

Gastric-type adenocarcinoma (GAS) is one of the most aggressive non-human papillomavirus (HPV)-associated cervical adenocarcinomas and remains especially difficult to diagnose and treat. It is often ...

NG-350A received FDA fast track designation for mismatch repair-proficient locally advanced rectal cancer, addressing a significant unmet need in treatment options. Imfinzi combined with FLOT ...